Autonomix Medical, Inc. AMIX
4.02
(0.05)
(1.23%)
as of 25 Sep
- Market cap
- $7.9M
- P/E
- 0.0×
Follow AMIX
| Dec '22 | Mar '23 | Dec '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|
Current Ratio |
— | 3.91 | 1.73 | 12.09 | 5.63 | 4.45 |
Net Debt/EBITDA |
0.00 | 0.43 | (0.08) | 0.64 | 0.80 | 0.41 |
Debt/Assets |
0.00% | 0.00% | 80.54% | 10.65% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (0.26) | 0.13 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
2.27 | 0.93 | 1.40 | 0.43 | 0.72 | 0.73 |
Capex/Depreciation |
0.00 | 0.00 | (0.46) | (0.23) | (0.08) | (0.83) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | 125.75% | (1,517.56%) | (145.10%) | (238.89%) | |
| 0.00% | (460.12%) | (232.83%) | (275.07%) | (118.77%) | (192.06%) | |
ROIC |
0.00% | 0.00% | 0.00% | (34,176.14%) | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | (309.01%) | (428.79%) | (178.75%) | (144.01%) | (283.55%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
0.00 | (64.83) | (0.23) | (134.69) | (98.36) | (35.78) |
Cash per Share |
— | 30.24 | 0.06 | 173.90 | 108.63 | 20.39 |
Shareholders Equity per Share |
0.00 | 22.52 | (0.29) | 154.10 | 96.30 | 17.16 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 22.52 | (0.29) | 154.10 | 96.30 | 17.16 |
Free Cash Flow |
(1.23) | (1.85) | (4.38) | (6.67) | (8.27) | (12.29) |
Working Capital |
— | 0.64 | 0.71 | 8.61 | 7.90 | 5.88 |
Capital Expenditures |
0.00 | 0.00 | (0.02) | (0.02) | (0.01) | (0.01) |
Net Current Asset Value |
0.00 | 0.64 | (5.72) | 7.61 | 7.90 | 5.88 |
| Other line items | ||||||
Quick Ratio |
— | 3.91 | 1.25 | 11.08 | 5.35 | 4.11 |
Depreciation/Fixed assets |
0.00 | 0.00 | 2.50 | 5.06 | 8.71 | 0.63 |
Cash ROIC |
0.00% | (122.86%) | 149.83% | (38.66%) | (48.04%) | (95.36%) |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
0.00 | (64.83) | (0.23) | (134.30) | (98.19) | (35.76) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.38) | (0.17) | (0.03) |
Average Payables |
— | — | 0.42 | 0.58 | 0.58 | 0.69 |
Average Assets |
— | 0.43 | 1.34 | 5.61 | 9.61 | 8.70 |
Average Common Equity |
— | — | (2.48) | 1.02 | 7.86 | 7.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates